Mogrify Ltd

Mogrify® is deploying its proprietary suite of cellular reprogramming technologies, MOGRIFY® and epiMOGRIFY, to develop scalable ex vivo cell therapies and in vivo reprogramming therapies for immuno-oncology, ophthalmology and other diseases with a high unmet clinical need.

Telephone: 01223 734154
Address :
25 Cambridge Science Park Milton Rd Cambridge
Post Code: CB4 0FW
Country: United Kingdom
Membership Type: Corporate 21-50